2009
DOI: 10.1667/rr1781.1
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapy in Conjunction with 7-Hydroxystaurosporine: A Multimodal Approach with Tumor pO2as a Potential Marker of Therapeutic Response

Abstract: Checkpoint inhibitors potentially could be used to enhance cell killing by DNA-targeted therapeutic modalities such as radiotherapy. UCN-01 (7-hydroxystaurosporine) inhibits S and G 2 checkpoint arrest in the cells of various malignant cell lines and has been investigated in combination with chemotherapy. However, little is known about its potential use in combination with radiotherapy. We report the effect of 20 Gy radiation given in conjunction with UCN-01 on the pO 2 and growth of subcutaneous RIF-1 tumors.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 30 publications
0
5
0
Order By: Relevance
“…This method has proven to be useful to identify possible areas of resistance during modulations of tumor hypoxia using drugs and anti-angiogenic treatments (3538). EPR oximetric imaging, however provides quantitative information on oxygenation and hypoxia from the whole imaged volume, and is therefore a more thorough tool to identify the hypoxic fractions within the tumors in order to improve the therapy outcome (23,39).…”
Section: Discussionmentioning
confidence: 99%
“…This method has proven to be useful to identify possible areas of resistance during modulations of tumor hypoxia using drugs and anti-angiogenic treatments (3538). EPR oximetric imaging, however provides quantitative information on oxygenation and hypoxia from the whole imaged volume, and is therefore a more thorough tool to identify the hypoxic fractions within the tumors in order to improve the therapy outcome (23,39).…”
Section: Discussionmentioning
confidence: 99%
“…Given the significant role of tumor hypoxia in therapeutic resistance and malignant progression, it is vital to develop strategies that can alleviate hypoxia as well as inhibit glioma growth. We have previously investigated the effect of an allosteric effector of hemoglobin (Efaproxiral), carbogen inhalation and radiotherapy on tumor pO 2 in orthotopic 9L, C6, CNS-1 and F98 glioma 11, 12, 33, 34 . Our goal is to characterize temporal changes in glioma pO 2 , improve oxygen level and treatment outcome.…”
Section: Discussionmentioning
confidence: 99%
“…We have previously investigated the effect of an allosteric effector of hemoglobin (Efaproxiral), carbogen inhalation and radiotherapy on tumor pO 2 in orthotopic 9L, C6, CNS-1 and F98 glioma. [11][12][13][14]33,34 Our goal is to characterize temporal changes in glioma pO 2 , improve oxygen level and treatment outcome. In this study, we have implemented a novel implantable resonator for monitoring cerebral pO 2 including orthotopic glioma in mice with EPR oximetry.…”
Section: Discussionmentioning
confidence: 99%
“…Since then, EPR oximetry has been engaged as a useful tool to measure the physiological concentrations of pO 2 in various tissues. EPR oximetry studies over recent years have included the development and testing of new paramagnetic spin probes 17, 19, pO 2 measurements in tumors 12, 14, 16–18, comparison with other methods 20 and monitoring of the dynamic changes in oxygen in tumors by modifying inhaled gases 12, 15–17, 21 or by pharmacological interventions 21. Thus, the majority of efforts have concentrated on the measurement of oxygen tension in tumors and the monitoring of pO 2 changes during the course of therapy 12, 14, 16, 17.…”
Section: Methods Of Noninvasive Imaging Of Hypoxiamentioning
confidence: 99%